Peer Review History

Original SubmissionFebruary 18, 2020
Decision Letter - Jerry Chun-Wei Lin, Editor

PONE-D-20-04677

Three corrections for overshoot effect improved the dose for step-and-shoot intensity-modulated radiation therapy.

PLOS ONE

Dear Dr. Hsu,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Nov 02 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Jerry Chun-Wei Lin

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. We suggest you thoroughly copyedit your manuscript for language usage, spelling, and grammar. If you do not know anyone who can help you do this, you may wish to consider employing a professional scientific editing service.  

Whilst you may use any professional scientific editing service of your choice, PLOS has partnered with both American Journal Experts (AJE) and Editage to provide discounted services to PLOS authors. Both organizations have experience helping authors meet PLOS guidelines and can provide language editing, translation, manuscript formatting, and figure formatting to ensure your manuscript meets our submission guidelines. To take advantage of our partnership with AJE, visit the AJE website (http://learn.aje.com/plos/) for a 15% discount off AJE services. To take advantage of our partnership with Editage, visit the Editage website (www.editage.com) and enter referral code PLOSEDIT for a 15% discount off Editage services.  If the PLOS editorial team finds any language issues in text that either AJE or Editage has edited, the service provider will re-edit the text for free.

Upon resubmission, please provide the following:

  • The name of the colleague or the details of the professional service that edited your manuscript
  • A copy of your manuscript showing your changes by either highlighting them or using track changes (uploaded as a *supporting information* file)
  • A clean copy of the edited manuscript (uploaded as the new *manuscript* file)

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: This is an interesting topic. The authors measured and listed the corrections for overshoot effect in step-and-shoot IMRT delivery.

Overshoot effect (multiple segments per field) cannot be caught from end effect test (one segment per field) in machine QA. And clinical physicists should know the limits of the machines when applying optimization parameters in TPS.

Clinically, there are two ways to avoid or reduce overshoot effect in most TPS by

1. increasing minimum segment MU and

2. limiting total number of segments per beam (increase minimum segment MU) during plan optimization.

Probably it can be mentioned in discussion.

For clinical plans which have multiple fields, very few segments, and low MUs, overshoot effect might be significant and lower GAMMA passing rate might be found.

Typo: line 135: should be “MU/min”, not “MJ/min”

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

When submitting your revision, we need you to address these additional

requirements.

1. Please ensure that your manuscript meets PLOS ONE's style

requirements, including those for file naming.

ANS: Yes, we did.

2. We suggest you thoroughly copyedit your manuscript for language

usage, spelling, and grammar. If you do not know anyone who can help you

do this, you may wish to consider employing a professional scientific

editing service.

ANS: Yes, we did. As the attached file, ***

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the

conclusions?

Reviewer #1: Yes

ANS: Thank Reviewer.

2. Has the statistical analysis been performed appropriately and

rigorously?

Reviewer #1: Yes

ANS: Thank Reviewer.

3. Have the authors made all data underlying the findings in their

manuscript fully available?

Reviewer #1: Yes

ANS: Thank Reviewer.

4. Is the manuscript presented in an intelligible fashion and written in

standard English?

Reviewer #1: Yes

ANS: Thank Reviewer.

5. Review Comments to the Author

Reviewer #1: This is an interesting topic. The authors measured and

listed the corrections for overshoot effect in step-and-shoot IMRT

delivery.

ANS: Thank Reviewer.

Overshoot effect (multiple segments per field) cannot be caught from end

effect test (one segment per field) in machine QA. And clinical

physicists should know the limits of the machines when applying

optimization parameters in TPS.

ANS: We agree.

Clinically, there are two ways to avoid or reduce overshoot effect in

most TPS by

1. increasing minimum segment MU and

2. limiting total number of segments per beam (increase minimum segment

MU) during plan optimization.

Probably it can be mentioned in discussion.

ANS: Thank Reviewer a lot. We did in new manuscript.

For clinical plans which have multiple fields, very few segments, and

low MUs, overshoot effect might be significant and lower GAMMA passing

rate might be found.

ANS: We agree.

Typo: line 135: should be "MU/min", not "MJ/min"

ANS: Thank Reviewer a lot. I changed "MJ/min" to "MU/min" at line 135 in new manuscript.

6. PLOS authors have the option to publish the peer review history of their article (what does this mean? [3]). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy [4].

Reviewer #1: No

ANS: We respect to Reviewer’s option.

Attachments
Attachment
Submitted filename: Response to Reviewers.docx
Decision Letter - Jerry Chun-Wei Lin, Editor

PONE-D-20-04677R1

Three corrections for overshoot effect improved the dose for step-and-shoot intensity-modulated radiation therapy.

PLOS ONE

Dear Dr. Hsu,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

==============================

ACADEMIC EDITOR: 

Please check the reviewer's comments to revise the manuscript

==============================

Please submit your revised manuscript by Feb 06 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Jerry Chun-Wei Lin

Academic Editor

PLOS ONE

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: From clinical plan perspective, not every step-and shoot IMRT plan should be corrected. Can author address more on the examples/plans that impacted by overshoot effect. For example, a publication, The step‐and‐shoot IMRT overshooting phenomenon: a novel method to mitigate patient overdosage. by Heming Zhen etc., found the correction can improve prostate plan QA passing rate. And another publication, Clinical implications of the overshoot effect for treatment

plan delivery and patient-specific quality assurance for step-and-shoot IMRT. by John A. Baines etc., compared prostate and head and neck plans.

QA passing rate can be improved with these corrections. But is it necessary to apply the correction for all step-and-shoot plan? Or if other methods used during plan optimization, like increasing minimum segment MU or reducing dose rate, can the correction can be waived?

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 2

Reviewer #1: From clinical plan perspective, not every step-and shoot IMRT plan should be corrected. Can author address more on the examples/plans that impacted by overshoot effect. For example, a publication, The step‐and‐shoot IMRT overshooting phenomenon: a novel method to mitigate patient overdosage. by Heming Zhen etc., found the correction can improve prostate plan QA passing rate. And another publication, Clinical implications of the overshoot effect for treatment plan delivery and patient-specific quality assurance for step-and-shoot IMRT. by John A. Baines etc., compared prostate and head and neck plans. QA passing rate can be improved with these corrections. But is it necessary to apply the correction for all step-and-shoot plan? Or if other methods used during plan optimization, like increasing minimum segment MU or reducing dose rate, can the correction can be waived?

ANS: Honestly, I have to confess that the plans with overshoot effect are much fewer, even served all cases in last year in our department. I also agree that overshoot effect was minimized as increasing segment MU or reducing dose rate. I also believe that increasing segment MU or reducing dose rate is most efficient to minimize overshoot effect. The above opinions were reported in our manuscript.

Block correction exclude overshoot and undershoot segments. Reverse-sequence correction, and index correction are compensate overshoot or undershoot segments to each other. Theoretically, overshoot effect could be reduce to zero with the three corrections, not only minimize overshoot effect. Unfortunately, before the corrections will be applied, corrections have to be approved by government. The other problem is time consuming for calculating the index of each segment and re-arranging the order of all segment. A computer program have to design for the problem.

I have to emphasize that the purpose in this report is evaluated and analyzed the availability of the three correction before the corrections are applied for clinical cases. I also have to emphasize that increasing segment MU or reducing dose rate is most efficient to minimize overshoot effect. I also believe that the result of overshoot effect as increasing segment MU or reducing dose rate is acceptable in clinical.

Attachments
Attachment
Submitted filename: Response to Reviewers.docx
Decision Letter - Jerry Chun-Wei Lin, Editor

Three corrections for overshoot effect improved the dose for step-and-shoot intensity-modulated radiation therapy.

PONE-D-20-04677R2

Dear Dr. Hsu,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Jerry Chun-Wei Lin

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Authors have addressed all the queries thus the paper is acceptable for the publication now

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Several correction techniques have been measured and compared for the overshoot effect in this article for step-and-shoot IMRT. Authors also well explained the measurement methods to distinguish the correction methods.

Reviewer #2: Please consider improving your reference list as it is very short, some suggestions:

Liu S, et al. Property of self-similarity between baseband and modulated signals. Mobile Networks and Applications. 2019 Sep 10:1-1.

Singh K, et al. Local Statistics-based Speckle Reducing Bilateral Filter for Medical Ultrasound Images. Mobile Networks and Applications. 2020 Dec;25(6):2367-89.

Połap D, et al. Neural image reconstruction using a heuristic validation mechanism. Neural Computing and Applications. 2020 Jun 20:1-1.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Formally Accepted
Acceptance Letter - Jerry Chun-Wei Lin, Editor

PONE-D-20-04677R2

Three corrections for overshoot effect improved the dose for step-and-shoot intensity-modulated radiation therapy

Dear Dr. Hsu:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Prof. Jerry Chun-Wei Lin

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .